These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24769493)

  • 1. In vivo mapping of a protective linear neutralizing epitope at the N-terminus of alpha hemolysin from Staphylococcus aureus.
    Oscherwitz J; Muñoz-Planillo R; Yu F; Núñez G; Cease KB
    Mol Immunol; 2014 Jul; 60(1):62-71. PubMed ID: 24769493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.
    Oscherwitz J; Cease KB
    PLoS One; 2015; 10(1):e0116882. PubMed ID: 25635901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent Evolution of Neutralizing Antibodies to Staphylococcus aureus γ-Hemolysin C That Recognize an Immunodominant Primary Sequence-Dependent B-Cell Epitope.
    Hernandez DN; Tam K; Shopsin B; Radke EE; Law K; Cardozo T; Torres VJ; Silverman GJ
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546616
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and application of a neutralizing epitope within alpha-hemolysin using human serum antibodies elicited by vaccination.
    Wei J; Cheng X; Zhang Y; Gao C; Wang Y; Peng Q; Luo P; Yang L; Zou Q; Zeng H; Gu J
    Mol Immunol; 2021 Jul; 135():45-52. PubMed ID: 33873093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise and efficient antibody epitope determination through library design, yeast display and next-generation sequencing.
    Van Blarcom T; Rossi A; Foletti D; Sundar P; Pitts S; Bee C; Melton Witt J; Melton Z; Hasa-Moreno A; Shaughnessy L; Telman D; Zhao L; Cheung WL; Berka J; Zhai W; Strop P; Chaparro-Riggers J; Shelton DL; Pons J; Rajpal A
    J Mol Biol; 2015 Mar; 427(6 Pt B):1513-1534. PubMed ID: 25284753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
    Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Adhikari RP; Thompson CD; Aman MJ; Lee JC
    Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin.
    Kernodle DS
    J Infect Dis; 2011 Jun; 203(11):1692-3; author reply 1693-4. PubMed ID: 21593000
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
    Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
    J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.
    Diep BA; Le VT; Visram ZC; Rouha H; Stulik L; Dip EC; Nagy G; Nagy E
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6333-40. PubMed ID: 27527081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia.
    Adhikari RP; Karauzum H; Sarwar J; Abaandou L; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Devi VS; Shulenin S; Warfield KL; Aman MJ
    PLoS One; 2012; 7(6):e38567. PubMed ID: 22701668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro and in vivo efficacy of a toxin-neutralizing human staphylococcal immunoglobulin].
    Hungerer KD; Ronneberger H
    Behring Inst Mitt; 1990 Oct; (86):170-84. PubMed ID: 2252461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin.
    Foletti D; Strop P; Shaughnessy L; Hasa-Moreno A; Casas MG; Russell M; Bee C; Wu S; Pham A; Zeng Z; Pons J; Rajpal A; Shelton D
    J Mol Biol; 2013 May; 425(10):1641-54. PubMed ID: 23416200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD36 Is Essential for Regulation of the Host Innate Response to Staphylococcus aureus α-Toxin-Mediated Dermonecrosis.
    Castleman MJ; Febbraio M; Hall PR
    J Immunol; 2015 Sep; 195(5):2294-302. PubMed ID: 26223653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
    Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
    MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective effects of active immunization against alpha hemolysin of Staphylococcus aureus].
    Wleklinski CG; Neubüser U; Ronneberger H; Hungerer KD; Schaeg W; Blobel H
    Zentralbl Veterinarmed B; 1982 Sep; 29(8):596-603. PubMed ID: 7180248
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination with VLPs Presenting a Linear Neutralizing Domain of
    Joyner JA; Daly SM; Peabody J; Triplett KD; Pokhrel S; Elmore BO; Adebanjo D; Peabody DS; Chackerian B; Hall PR
    Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32664481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
    Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
    mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
    Uppalapati SR; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auto-Assembling Detoxified Staphylococcus aureus Alpha-Hemolysin Mimicking the Wild-Type Cytolytic Toxin.
    Fiaschi L; Di Palo B; Scarselli M; Pozzi C; Tomaszewski K; Galletti B; Nardi-Dei V; Arcidiacono L; Mishra RP; Mori E; Pallaoro M; Falugi F; Torre A; Fontana MR; Soriani M; Bubeck Wardenburg J; Grandi G; Rappuoli R; Ferlenghi I; Bagnoli F
    Clin Vaccine Immunol; 2016 Jun; 23(6):442-50. PubMed ID: 27030589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.